Current Australian Grants

JDRF Grants

Name

Institution

Project Title

A/Prof. Shane Grey Garvan Institute of Medical Research Islet dependent tolerance for insulin independence without immunosuppression
Dr. Mugdha Joglekar University of Sydney Plasma RNA Evaluation and Diagnosis In Children progressing To Type 1 Diabetes (PREDICT T1D)
Dr. Emma Hamilton-Williams University of Queensland A genetic link between gut microbial flora and T1D susceptibility
Dr. Jane Mullaney University of Queensland A link between the gut microbiome and type 1 diabetes
Prof. Ranjeny Thomas University of Queensland Antigen-specific peptide immunotherapy targeting dendritic cells in type 1 diabetes
Dr. Ahmed Mehdi University of Queensland Developing models of T1D progression by integrating clinical and genomic data
Prof. Jennifer Couper University of Adelaide Early environmental determinants of pancreatic islet autoimmunity (ENDIA)
Prof. Jennifer Couper University of Adelaide Centre of Research Excellence for pancreatic beta-cell protection and preservation
Prof. Patrick Coates Royal Adelaide Hospital Vascularised Biodegradable Temporizing Matrix as an Alternative Site for Islet Transplantation
Dr. Christoph Hagemeyer Monash University Smart insulin delivery with glucose responsive nanomaterials
Dr. Bryna Chow Monash University The therapeutic potential of Compound 21 (Angiotensin II type 2 receptor agonist) in diabetic nephropathy
Prof. Anthony Purcell Monash University A peptidomics approach to understanding the fate and antigen presentation of post-translationally modified proteins in type 1 diabetes
A/Prof. Stuart Mannering St Vincent's Institute of Medical Research Molecular and functional analysis of human islet-infiltrating T cells
Dr. John Wentworth Walter and Eliza Hall Institute of Medical Research Type 1 Diabetes TrialNet International Site - Australia/New Zealand
Prof. Len Harrison Walter and Eliza Hall Institute of Medical Research Intranasal Insulin Trial II
Dr. Sih Min tan Monash University Targeting the C5a-C5aR1 signaling axis in diabetic nephropathy
Prof. Mark Cooper Monash University New targets and therapies in diabetic complications
Dr. Jay Jha Monash University The relative role of NADPH oxidase-Nox5 versus Nox4 in type 1 diabetic nephropathy: in vitro and in vivo studies
A/Prof. Helen Thomas St Vincent's Institute of Medical Research Blocking the interaction between T cells and beta cells using JAK inhibitors
Dr.Eliana Marino Monash University Dietary Manipulation of Gut Microbial Metabolites Mitigate Type 1 Diabetes
A/Prof. Helen Thomas St Vincent's Institute of Medical Research Investigating whether endogenously-derived cytosolic nucleic acids trigger type 1 diabetes
Dr. Esteban Gurzov St Vincent's Institute of Medical Research The role of Protein Tyrosine Phosphatases in pancreatic beta cell function and survival
Dr. Thomas Loudovaris St Vincent's Institute of Medical Research  Pairing of genetically modified pig tissue with TheraCyte encapsulation devices
Prof. Peter Cowan St Vincent's Hospital Genetic modification to protect pig islets from T cell-mediated xenogenic rejection
Dr. Sybil McAuley University of Melbourne Advancement of Automated Insulin Delivery for Adults with Type 1 Diabetes
Dr. Devy Deliyanti Monash University Boosting the immune system to treat diabetic retinopathy
Dr. Andrew Sutherland St Vincent's Institute of Medical Research  Type 17 immunity in type 1 diabetes
Dr. Satoru Akazawa St Vincent's Institute of Medical Research  Defining a new role for granzyme A in maintaining immune tolerance
Dr. Thomas Brodnicki St Vincent's Institute of Medical Research  Amino acid transport: a new target for modulating immune cell destruction of beta cells
Prof. Tim Jones University of Western Australia Improving the lives of young people with Type 1 Diabetes Care using State-of-the-Art Therapies

 

Clinical Research Grants

JDRF is also awarding a number of grants through the Australian Type 1 Diabetes Clinical Research Network (T1DCRN). For more information, please see the T1DCRN website.